David T Doherty Surgery Partners, Inc. (SGRY) insider trading activity

David T Doherty is Chief Financial Officer of Surgery Partners, Inc.. Currently has a direct ownership of 95,719 shares of SGRY, which is worth approximately $2.28 Million. The most recent transaction as insider was on Mar 14, 2024, when has been sold 721 shares (Common Stock) at a price of $28.59 per share, resulting in proceeds of $20,613. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 95.7K

0% 3M change

20.04% 12M change

Total Value Held $2.28 Million

David T Doherty Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 14 2024	SELL Open market or private sale	$20,613 $28.59 p/Share	721 Reduced 0.75%	95,719 Common Stock
Mar 04 2024	SELL Open market or private sale	$104,047 $30.37 p/Share	3,426 Reduced 3.43%	96,440 Common Stock
Feb 28 2024	BUY Grant, award, or other acquisition	$799,985 $31.18 p/Share	25,657 Added 20.44%	99,866 Common Stock
Feb 12 2024	SELL Open market or private sale	$35,628 $34.93 p/Share	1,020 Reduced 1.36%	74,209 Common Stock
Feb 02 2024	SELL Open market or private sale	$73,538 $31.89 p/Share	2,306 Reduced 2.97%	75,229 Common Stock
Aug 30 2023	SELL Open market or private sale	$72,240 $36.12 p/Share	2,000 Reduced 2.51%	77,535 Common Stock
Aug 29 2023	SELL Open market or private sale	$7,112 $35.21 p/Share	202 Reduced 0.25%	79,535 Common Stock

Mar 15 2023	SELL Open market or private sale	$632 $30.11 p/Share	21 Reduced 0.03%	79,737 Common Stock
Mar 14 2023	SELL Open market or private sale	$83,032 $31.11 p/Share	2,669 Reduced 3.24%	79,758 Common Stock
Mar 13 2023	SELL Open market or private sale	$20,364 $29.86 p/Share	682 Reduced 0.82%	82,427 Common Stock
Mar 03 2023	SELL Open market or private sale	$679,599 $33.98 p/Share	20,000 Reduced 19.4%	83,109 Common Stock
Mar 02 2023	BUY Grant, award, or other acquisition	$1,699,979 $32.86 p/Share	51,734 Added 33.41%	103,109 Common Stock
Feb 27 2023	SELL Open market or private sale	$144,681 $33.53 p/Share	4,315 Reduced 7.75%	51,375 Common Stock
Feb 13 2023	SELL Open market or private sale	$31,952 $33.92 p/Share	942 Reduced 1.66%	55,690 Common Stock
Feb 02 2023	SELL Open market or private sale	$69,897 $35.9 p/Share	1,947 Reduced 3.32%	56,632 Common Stock
Aug 30 2022	SELL Open market or private sale	$5,070 $29.65 p/Share	171 Reduced 0.29%	58,579 Common Stock
Mar 16 2022	SELL Open market or private sale	$55,532 $50.9 p/Share	1,091 Reduced 1.82%	58,750 Common Stock
Mar 15 2022	SELL Open market or private sale	$181,289 $49.29 p/Share	3,678 Reduced 5.79%	59,841 Common Stock
Mar 11 2022	SELL Open market or private sale	$20,563 $54.69 p/Share	376 Reduced 0.59%	63,519 Common Stock
Feb 25 2022	SELL Open market or private sale	$112,116 $50.48 p/Share	2,221 Reduced 3.6%	59,435 Common Stock
Feb 10 2022	BUY Grant, award, or other acquisition	$187,498 $42.04 p/Share	4,460 Added 6.52%	63,895 Common Stock
Feb 01 2022	BUY Grant, award, or other acquisition	$599,962 $44.8 p/Share	13,392 Added 17.84%	61,656 Common Stock

DTD

David T Doherty

Chief Financial Officer

Brentwood, TN

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SGRY shares.

Notify only if

Value

Insider Trading

Get notified when an Surgery Partners, Inc. insider buys or sells SGRY shares.

Notify only if

Operation

Value

Type

News

Receive news related to Surgery Partners, Inc.

Track Activities on SGRY

Account